Jacob P Christ, Rachel Blank, Heather G Huddleston
{"title":"基于美国人口的多囊卵巢综合症女性群体对医疗服务不满意的决定因素。","authors":"Jacob P Christ, Rachel Blank, Heather G Huddleston","doi":"10.1210/clinem/dgae556","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>The 2018 International Evidence-Based Guidelines (IEBG) for polycystic ovary syndrome (PCOS) were created, in part, in response to poor patient satisfaction on international surveys. Patient satisfaction in the United States before and after these guidelines has not yet been characterized.</p><p><strong>Objective: </strong>To evaluate care patterns and patient attitudes among US women with PCOS before and after IEBG.</p><p><strong>Methods: </strong>This was a cross-sectional study of a population-based community sample of US women with confirmed PCOS who completed standardized questionnaires on care patterns and satisfaction in care.</p><p><strong>Results: </strong>Among 1056 respondents, aged 23 ± 6 years at diagnosis, 69.2% had to wait ≥ 1 year and 72.9% saw > 1 provider prior to receiving a diagnosis. Less than 45% strongly agreed or agreed with statements regarding trusting their doctor and < 27% were very or somewhat satisfied with care across all questions. In multivariable analyses, composite outcome of trusting your physician was associated with insurance type (uninsured vs private) (odds ratio [95% CI] 0.5 [0.3-0.9], P = .020), race (Hispanic vs Caucasian) (0.6 [0.5-0.9], P = .007), (Black vs Caucasian) (1.6 [1.0-2.4], P = .045) and timing of diagnosis (within 5 years vs > 5 years) (1.3 [1.0-1.7], P = .038). Care satisfaction was associated with insurance type (public vs private) (0.6 [0.4-0.9], P = .010), (uninsured vs private) (0.5 [0.3-0.9], P = .021), and timing of diagnosis (within 5 years vs > 5 years) (1.4 [1.1-1.9], P = .010).</p><p><strong>Conclusion: </strong>Satisfaction and trust in care is overall poor among US patients with PCOS. Higher scores among those diagnosed within the past 5 years, compared to those with a more remote diagnosis, may indicate an improving trend in care.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"838-846"},"PeriodicalIF":5.0000,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Determinants of Health Care Dissatisfaction Among a US Population-Based Cohort of Women With Polycystic Ovary Syndrome.\",\"authors\":\"Jacob P Christ, Rachel Blank, Heather G Huddleston\",\"doi\":\"10.1210/clinem/dgae556\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Context: </strong>The 2018 International Evidence-Based Guidelines (IEBG) for polycystic ovary syndrome (PCOS) were created, in part, in response to poor patient satisfaction on international surveys. Patient satisfaction in the United States before and after these guidelines has not yet been characterized.</p><p><strong>Objective: </strong>To evaluate care patterns and patient attitudes among US women with PCOS before and after IEBG.</p><p><strong>Methods: </strong>This was a cross-sectional study of a population-based community sample of US women with confirmed PCOS who completed standardized questionnaires on care patterns and satisfaction in care.</p><p><strong>Results: </strong>Among 1056 respondents, aged 23 ± 6 years at diagnosis, 69.2% had to wait ≥ 1 year and 72.9% saw > 1 provider prior to receiving a diagnosis. Less than 45% strongly agreed or agreed with statements regarding trusting their doctor and < 27% were very or somewhat satisfied with care across all questions. In multivariable analyses, composite outcome of trusting your physician was associated with insurance type (uninsured vs private) (odds ratio [95% CI] 0.5 [0.3-0.9], P = .020), race (Hispanic vs Caucasian) (0.6 [0.5-0.9], P = .007), (Black vs Caucasian) (1.6 [1.0-2.4], P = .045) and timing of diagnosis (within 5 years vs > 5 years) (1.3 [1.0-1.7], P = .038). Care satisfaction was associated with insurance type (public vs private) (0.6 [0.4-0.9], P = .010), (uninsured vs private) (0.5 [0.3-0.9], P = .021), and timing of diagnosis (within 5 years vs > 5 years) (1.4 [1.1-1.9], P = .010).</p><p><strong>Conclusion: </strong>Satisfaction and trust in care is overall poor among US patients with PCOS. Higher scores among those diagnosed within the past 5 years, compared to those with a more remote diagnosis, may indicate an improving trend in care.</p>\",\"PeriodicalId\":50238,\"journal\":{\"name\":\"Journal of Clinical Endocrinology & Metabolism\",\"volume\":\" \",\"pages\":\"838-846\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2025-02-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Endocrinology & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1210/clinem/dgae556\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae556","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:2018 年多囊卵巢综合症国际循证指南(IEBG)的制定在一定程度上是对国际调查中患者满意度较低的回应。在这些指南出台前后,美国患者的满意度尚无定论:评估 IEBG 制定前后美国多囊卵巢综合症妇女的护理模式和患者态度:设计:横断面:患者或其他参与者:干预措施:无:干预措施:无:主要结果测量:关于护理模式和护理满意度的标准化问卷:结果:共纳入1056名受访者,诊断时年龄为23±6岁。69.2%的受访者在确诊前需要等待1年以上,72.9%的受访者在确诊前看了1个以上的医疗机构。5年)(1.3(1.0-1.7),P=0.038)。护理满意度与保险类型(公共保险 vs 私人保险)(0.6 (0.4-0.9),p=0.010)、(无保险 vs 私人保险)(0.5 (0.3-0.9),p=0.021)和诊断时间(5 年内 vs >5 年)(1.4 (1.1-1.9),p=0.010)有关:结论:美国多囊卵巢综合症患者对医疗服务的满意度和信任度总体较低。与诊断时间较远的患者相比,在过去 5 年内确诊的患者得分较高,这可能预示着医疗服务的改善趋势。
Determinants of Health Care Dissatisfaction Among a US Population-Based Cohort of Women With Polycystic Ovary Syndrome.
Context: The 2018 International Evidence-Based Guidelines (IEBG) for polycystic ovary syndrome (PCOS) were created, in part, in response to poor patient satisfaction on international surveys. Patient satisfaction in the United States before and after these guidelines has not yet been characterized.
Objective: To evaluate care patterns and patient attitudes among US women with PCOS before and after IEBG.
Methods: This was a cross-sectional study of a population-based community sample of US women with confirmed PCOS who completed standardized questionnaires on care patterns and satisfaction in care.
Results: Among 1056 respondents, aged 23 ± 6 years at diagnosis, 69.2% had to wait ≥ 1 year and 72.9% saw > 1 provider prior to receiving a diagnosis. Less than 45% strongly agreed or agreed with statements regarding trusting their doctor and < 27% were very or somewhat satisfied with care across all questions. In multivariable analyses, composite outcome of trusting your physician was associated with insurance type (uninsured vs private) (odds ratio [95% CI] 0.5 [0.3-0.9], P = .020), race (Hispanic vs Caucasian) (0.6 [0.5-0.9], P = .007), (Black vs Caucasian) (1.6 [1.0-2.4], P = .045) and timing of diagnosis (within 5 years vs > 5 years) (1.3 [1.0-1.7], P = .038). Care satisfaction was associated with insurance type (public vs private) (0.6 [0.4-0.9], P = .010), (uninsured vs private) (0.5 [0.3-0.9], P = .021), and timing of diagnosis (within 5 years vs > 5 years) (1.4 [1.1-1.9], P = .010).
Conclusion: Satisfaction and trust in care is overall poor among US patients with PCOS. Higher scores among those diagnosed within the past 5 years, compared to those with a more remote diagnosis, may indicate an improving trend in care.
期刊介绍:
The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.